Literature DB >> 8732754

Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.

V Ganesh1, A Y Lee, J Clardy, A Tulinsky.   

Abstract

Thrombin, a trypsin-like serine protease present in blood, plays a central role in the regulation of thrombosis and hemostasis. A cyclic pentapeptide, cyclotheonamide A (CtA), isolated from sponges of the genus Theonella, inhibits thrombin, trypsin, and certain other serine proteases. Enzyme inhibition data for CtA indicate that it is a moderate inhibitor of alpha-thrombin (K(i) = 1.0 nM), but substantially more potent toward trypsin (K(i) = 0.2 nM). The comparative study of the crystal structures of the CtA complexes of alpha-thrombin and beta-trypsin reported here focuses on structure-function relationships in general and the enhanced specificity of trypsin, in particular. The crystal structures of the CtA complexes of thrombin and trypsin were solved and refined at 1.7 and 2.0 A resolution, respectively. The structures show that CtA occupies the active site with the Pro-Arg motif positioned in the S2 and S1 binding sites. The alpha-keto group of CtA is involved in a tetrahedral intermediate hemiketal structure with Ser 195 OG of the catalytic triad and is positioned within bonding distance from, and orthogonal to, the re-face of the carbonyl of the arginine of CtA. As in other productive binding modes of serine proteases, the Ser 214-Gly 216 segment runs in a twisted antiparallel beta-strand manner with respect to the diaminopropionic acid (Dpr)-Arg segment of CtA. The Tyr 60A-Thr 60I insertion loop of thrombin makes a weak aromatic stacking interaction with the v-Tyr of CtA through Trp 60D. The Glu 39 Tyr and Leu 41 Phe substitutions in trypsin produce an enhanced aromatic interaction with D-Phe of CtA, which also leads to different orientations of the side chains of D-Phe and the v-Tyr. The comparison of the CtA complexes of thrombin and trypsin shows that the gross structural features of both in the active site region are the same, whereas the differences observed are mainly due to minor insertions and substitutions. In trypsin, the substitution of Ile 174-Arg 175 by Gly 174-Gln 175 makes the S3 aryl site more polar because the Arg 175 side chain is directed away from thrombin and into the solvent, whereas Gln 175 is not. Because the site is occupied by the Dpr group of CtA, the occupancy of the S3 site is better in trypsin than in thrombin. In trypsin, the D-Phe side chain of CtA fits between Tyr 39 and Phe 41 in a favorable manner, whereas in thrombin, these residues are Glu 39 and Leu 41. The higher degree of specificity for trypsin is most likely the result of these substitutions and the absence of the fairly rigid Tyr 60A-Thr 60I insertion loop of thrombin, which narrows access to the active site and forces less favorable orientations for the D-Phe and v-Tyr residues.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8732754      PMCID: PMC2143408          DOI: 10.1002/pro.5560050504

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  18 in total

Review 1.  HIV protease: a novel chemotherapeutic target for AIDS.

Authors:  J R Huff
Journal:  J Med Chem       Date:  1991-08       Impact factor: 7.446

Review 2.  Regulation of thrombin generation and functions.

Authors:  J W Fenton
Journal:  Semin Thromb Hemost       Date:  1988-07       Impact factor: 4.180

3.  Inactivation of trypsin-like enzymes with peptides of arginine chloromethyl ketone.

Authors:  C Kettner; E Shaw
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

4.  D-Phe-Pro-ArgCH2C1-A selective affinity label for thrombin.

Authors:  C Kettner; E Shaw
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

5.  Crystal structure of bovine beta-trypsin at 1.5 A resolution in a crystal form with low molecular packing density. Active site geometry, ion pairs and solvent structure.

Authors:  H D Bartunik; L J Summers; H H Bartsch
Journal:  J Mol Biol       Date:  1989-12-20       Impact factor: 5.469

6.  Localization of a chemotactic domain in human thrombin.

Authors:  R Bar-Shavit; A Kahn; M S Mudd; G D Wilner; K G Mann; J W Fenton
Journal:  Biochemistry       Date:  1984-01-31       Impact factor: 3.162

7.  Highly active and selective anticoagulants: D-Phe-Pro-Arg-H, a free tripeptide aldehyde prone to spontaneous inactivation, and its stable N-methyl derivative, D-MePhe-Pro-Arg-H.

Authors:  S Bajusz; E Szell; D Bagdy; E Barabas; G Horvath; M Dioszegi; Z Fittler; G Szabo; A Juhasz; E Tomori
Journal:  J Med Chem       Date:  1990-06       Impact factor: 7.446

8.  Synthesis of peptidyl fluoromethyl ketones and peptidyl alpha-keto esters as inhibitors of porcine pancreatic elastase, human neutrophil elastase, and rat and human neutrophil cathepsin G.

Authors:  N P Peet; J P Burkhart; M R Angelastro; E L Giroux; S Mehdi; P Bey; M Kolb; B Neises; D Schirlin
Journal:  J Med Chem       Date:  1990-01       Impact factor: 7.446

9.  Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes.

Authors:  I I Mathews; K P Padmanabhan; V Ganesh; A Tulinsky; M Ishii; J Chen; C W Turck; S R Coughlin; J W Fenton
Journal:  Biochemistry       Date:  1994-03-22       Impact factor: 3.162

10.  The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment.

Authors:  W Bode; I Mayr; U Baumann; R Huber; S R Stone; J Hofsteenge
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.